Cargando…
Survivin family proteins as novel molecular determinants of doxorubicin resistance in organotypic human breast tumors
INTRODUCTION: The molecular determinants of breast cancer resistance to first-line anthracycline-containing chemotherapy are unknown. METHODS: We examined the response to doxorubicin of organotypic cultures of primary human breast tumors ex vivo with respect to cell proliferation, DNA damage and mod...
Autores principales: | Faversani, Alice, Vaira, Valentina, Moro, Giacomina P, Tosi, Delfina, Lopergolo, Alessia, Schultz, David C, Rivadeneira, Dayana, Altieri, Dario C, Bosari, Silvano |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4076638/ https://www.ncbi.nlm.nih.gov/pubmed/24886669 http://dx.doi.org/10.1186/bcr3666 |
Ejemplares similares
-
miR-296 regulation of a cell polarity-cell plasticity module controls tumor progression
por: Vaira, Valentina, et al.
Publicado: (2011) -
A New Mouse Avatar Model of Non-Small Cell Lung Cancer
por: Russo, Maria Veronica, et al.
Publicado: (2015) -
miR-494-3p is a novel tumor driver of lung carcinogenesis
por: Faversani, Alice, et al.
Publicado: (2016) -
The Mitochondrial Unfoldase-Peptidase Complex ClpXP Controls Bioenergetics Stress and Metastasis
por: Seo, Jae Ho, et al.
Publicado: (2016) -
Mismatch Repair Protein Loss as a Prognostic and Predictive Biomarker in Breast Cancers Regardless of Microsatellite Instability
por: Fusco, Nicola, et al.
Publicado: (2018)